ARMO BioSciences, Inc.

Home » ARMO BioSciences, Inc.

IPO

ARMO BioSciences, Inc.

They are a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors.

Symbol

ARMO

Price Range
TBD

Anticipated Shares
7,500,000

Effective Date
January 26, 2018

Underwriters
Jefferies, Leerink, BMO Capital Markets

To view the prospectus for ARMO BioSciences, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253